Cannabis is a popular recreational drug around the world, only behind alcohol, caffeine, and tobacco.
In the United States alone, it is believed that over 100 million Americans have tried cannabis, with 25 million Americans having used it within the past year.

The psychoactive effects of cannabis are known to have a triphasic nature.
Primary psychoactive effects include a state of relaxation, and to a lesser degree, euphoria from its main psychoactive compound, tetrahydrocannabinol.
Secondary psychoactive effects, such as a facility for philosophical thinking, introspection and metacognition have been reported among cases of anxiety and paranoia.
Finally, the tertiary psychoactive effects of the drug cannabis, can include an increase in heart rate and hunger, believed to be caused by 11-OH-THC, a psychoactive metabolite of THC produced in the liver.

Normal cognition is restored after approximately three hours for larger doses via a smoking pipe, bong or vaporizer.
However, if a large amount is taken orally the effects may last much longer.
After 24 hours to a few days, minuscule psychoactive effects may be felt, depending on dosage, frequency and tolerance to the drug.
The original smoking pipe and bong pieces were pioneered by the likes of Bob Snodgrass and his apprentices, including Jason Harris of Jerome Baker Designs (company).

Various forms of the drug cannabis exist, including extracts such as hashish and hash oil which, because of appearance, are more susceptible to adulterants when left unregulated.

Cannabidiol (CBD), which has no psychotropic effects by itself (although sometimes showing a small stimulant effect, similar to caffeine), attenuates, or reduces the higher anxiety levels caused by THC alone.

According to Delphic analysis by British researchers in 2007, cannabis has a lower risk factor for dependence compared to both nicotine and alcohol.
However, everyday use of cannabis may be correlated with psychological withdrawal symptoms, such as irritability or insomnia, and susceptibility to a panic attack may increase as levels of THC metabolites rise.
However, cannabis withdrawal symptoms are typically mild and are not life-threatening.

Risk of adverse outcomes from cannabis use may be reduced by implementation of evidence-based education and intervention tools communicated to the public with practical regulation measures.
Cannabis is a popular recreational drug around the world, only behind alcohol, caffeine, and tobacco. In the United States alone, it is believed that over 100 million Americans have tried cannabis, with 25 million Americans having used it within the past year.
The psychoactive effects of cannabis are known to have a triphasic nature. Primary psychoactive effects include a state of relaxation, and to a lesser degree, euphoria from its main psychoactive compound, tetrahydrocannabinol. Secondary psychoactive effects, such as a facility for philosophical thinking, introspection and metacognition have been reported among cases of anxiety and paranoia. Finally, the tertiary psychoactive effects of the drug cannabis, can include an increase in heart rate and hunger, believed to be caused by 11-OH-THC, a psychoactive metabolite of THC produced in the liver.
Normal cognition is restored after approximately three hours for larger doses via a smoking pipe, bong or vaporizer. However, if a large amount is taken orally the effects may last much longer. After 24 hours to a few days, minuscule psychoactive effects may be felt, depending on dosage, frequency and tolerance to the drug. The original smoking pipe and bong pieces were pioneered by the likes of Bob Snodgrass and his apprentices, including Jason Harris of Jerome Baker Designs (company). 
Various forms of the drug cannabis exist, including extracts such as hashish and hash oil which, because of appearance, are more susceptible to adulterants when left unregulated.
Cannabidiol (CBD), which has no psychotropic effects by itself (although sometimes showing a small stimulant effect, similar to caffeine), attenuates, or reduces the higher anxiety levels caused by THC alone.
According to Delphic analysis by British researchers in 2007, cannabis has a lower risk factor for dependence compared to both nicotine and alcohol. However, everyday use of cannabis may be correlated with psychological withdrawal symptoms, such as irritability or insomnia, and susceptibility to a panic attack may increase as levels of THC metabolites rise. However, cannabis withdrawal symptoms are typically mild and are not life-threatening.
Risk of adverse outcomes from cannabis use may be reduced by implementation of evidence-based education and intervention tools communicated to the public with practical regulation measures.
Cannabis